Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000735139 | SCV000863340 | uncertain significance | not provided | 2018-09-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000813915 | SCV000954299 | uncertain significance | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2022-07-19 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 732 of the SYNE1 protein (p.Thr732Met). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 598683). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. This variant is present in population databases (rs374866393, gnomAD 0.01%). |
Athena Diagnostics | RCV000735139 | SCV002771367 | uncertain significance | not provided | 2021-07-16 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000735139 | SCV003826388 | uncertain significance | not provided | 2023-05-11 | criteria provided, single submitter | clinical testing |